1. Home
  2. BFC vs IMCR Comparison

BFC vs IMCR Comparison

Compare BFC & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$136.37

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$33.03

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
IMCR
Founded
1894
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
BFC
IMCR
Price
$136.37
$33.03
Analyst Decision
Buy
Buy
Analyst Count
2
11
Target Price
$150.00
$64.70
AVG Volume (30 Days)
75.9K
379.9K
Earning Date
04-23-2026
01-01-0001
Dividend Yield
1.46%
N/A
EPS Growth
11.23
30.39
EPS
7.23
N/A
Revenue
N/A
$249,428,000.00
Revenue This Year
$58.67
$14.39
Revenue Next Year
$2.01
$8.19
P/E Ratio
$18.87
N/A
Revenue Growth
N/A
43.05
52 Week Low
$93.00
$23.15
52 Week High
$153.00
$40.71

Technical Indicators

Market Signals
Indicator
BFC
IMCR
Relative Strength Index (RSI) 43.64 50.92
Support Level $118.71 $31.21
Resistance Level $140.92 $34.86
Average True Range (ATR) 4.21 1.72
MACD -1.20 0.10
Stochastic Oscillator 28.64 57.18

Price Performance

Historical Comparison
BFC
IMCR

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: